Ethyleneoxynitazene
![]()  | |
| Identifiers | |
|---|---|
  | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C22H26N4O3 | 
| Molar mass | 394.475 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
Ethyleneoxynitazene (Tetrahydrofuranitazene) is a benzimidazole derivative which has been sold as a designer drug over the internet and has opioid effects, though with lower potency than etonitazene itself[1] It is an analogue of etonitazene where the 4-ethoxy group attached to the benzyl ring has been cyclised round to the 3-position to form a 2,3-dihydrobenzofuran ring system. It was first reported in Estonia in February 2023,[2] subsequently in the UK in late 2023[3] and in China July 1st.[4]
See also
- Etonitazepyne
 - Etomethazene
 - Isotonitazene
 - Methylenedioxynitazene
 - List of benzimidazole opioids
 - Substituted benzofuran
 
References
- ^ Gatch MB, Hill RD, Sundar M, Shetty RA (July 2025). "Discriminative stimulus and antinociceptive effects of sixteen nitazene analogs in rodents". Neuropharmacology. 272 110416: 110416. doi:10.1016/j.neuropharm.2025.110416. PMID 40120927.
 - ^ "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
 - ^ "Third addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids" (PDF). Advisory Council on the Misuse of Drugs. 15 December 2023.
 - ^ "Reddit - Dive into anything". www.reddit.com. Retrieved 2024-10-16.
 
